1Russo D,Meoli B, Andreucci VE. The place of loop diuretics in the treatment of acute and chronic renal failure. Clin Nephrol, 1992,38(Suppl1):S69-S73
2Faller B, Lamerire N.Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7years. Nephrol Dial Transplant, 1994, 9:280-286
3Medcalf JF, Harris KP, Walls J. Role of diuretics in the preservation of renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int, 2001,59:1128-1133
4Acchiardo SR, Skoutakis VA. Clinical efficacy,safety,and pharmacokinetics of indapamide in renal impairment. Am Heart J, 1983,106:237-244
5van Olden RW,van Meyel JJ,Gerlag PGG. Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients. Am J Nephrol, 1992,12:351-356
6van Olden RW,van Meyel JJM,Geriag PGG. Chronic high dosage furosemide in haemodialysis patients. In Puschett JB, editor. Diuretics III: chemistry, pharmodialysis, and clinical applications. Amsterdam: Elsevier Science,1990,PP.25-27
7Schulz W, Dorfler A, Stiehl L, Achhammer I. Double-blind clinical trial investgating the efficacy and long-term tolerance of torasemide 200mg p.o. compared with furosemide 500 p.o.in patients with chronic renal failure on hemodialysis, a multicenter study. Prog Pharmacol Clin Pharmacol, 1990,8:249-257
9Beermann B. Aspects into pharmacokinetics of some diuretics. Acta Pharmacol Toxicol (Copenh),1984,54(Suppl 1):17-29
10Gehr TW, Rudy DW, Matzke GR, et al. The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency. Kidney. Clin Pharmacol Ther, 1994,56:31-38
二级参考文献1
1R. W. Olden,J. J. M. Meyel,P. G. G. Gerlag. Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency[J] 1995,European Journal of Clinical Pharmacology(6):483～488
